TWD 4.24
(3.16%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 23.39 Million | 21.36 Million | 68.69 Million | -37.79 Million | - |
Net Income | -73.61 Million | 4.29 Million | 8.26 Million | -77.43 Million | - |
Depreciation & Amortization | 48.08 Million | 53.51 Million | 55.56 Million | 62.87 Million | - |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - |
Change in working capital | 42.8 Million | -36.08 Million | 4.57 Million | -21.14 Million | - |
Other non-cash items | 13.94 Million | 14.63 Million | 12.85 Million | 11.55 Million | - |
Investing Cash Flow | 22.27 Million | -17.47 Million | -23.63 Million | 1.65 Million | - |
Investments in PPE | -13.19 Million | -26.83 Million | -14.84 Million | -12.11 Million | - |
Acquisitions | 870 Thousand | - | - | - | - |
Investment purchases | -1.6 Million | - | - | - | - |
Sales/Maturities of investments | -1.6 Million | 12.88 Million | 8.81 Million | 21.12 Million | - |
Other Investing Activities | 36.21 Million | -5.62 Million | -17.85 Million | -7.57 Million | - |
Financing Cash Flow | -27.77 Million | 12.19 Million | -36.63 Million | 35.09 Million | - |
Debt repayment | -47.55 Million | -28.81 Million | -35.38 Million | -23.81 Million | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - |
Common Stock Issuance | 30 Million | - | - | 20.4 Million | - |
Other Financing Activities | -10.22 Million | -7.2 Million | 7.2 Million | - | -90 Thousand |
Accounts receivables | 52.66 Million | - | - | - | - |
Accounts payables | -30.19 Million | - | - | - | - |
Inventory | 35.02 Million | -24.9 Million | -16.91 Million | -647 Thousand | - |
Other working capital | -44.89 Million | - | - | - | - |
Cash at beginning of period | 50.4 Million | 33.42 Million | 25.16 Million | 25.83 Million | - |
Cash at end of period | 67.91 Million | 50.4 Million | 33.42 Million | 25.16 Million | - |
Capital Expenditure | -13.19 Million | -26.83 Million | -14.84 Million | -12.11 Million | - |
Effect of forex changes on cash | -392 Thousand | 895 Thousand | -172 Thousand | 386 Thousand | - |
Net cash flow / Change in cash | 17.5 Million | 16.98 Million | 8.26 Million | -668 Thousand | - |
Free Cash Flow | 10.2 Million | -5.46 Million | 53.85 Million | -49.9 Million | - |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -6.08 Million | -6.08 Million | -20.52 Million | -73.61 Million | -20.52 Million | -15.62 Million |
Depreciation & Amortization | 8.66 Million | 8.66 Million | 11.75 Million | 48.08 Million | 11.75 Million | 12.28 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -13.24 Million | -13.24 Million | 9.63 Million | 42.8 Million | 9.63 Million | 26.41 Million |
Other non-cash items | 9.37 Million | 9.37 Million | -1.13 Million | 13.94 Million | -1.13 Million | -11.11 Million |
Investing Cash Flow | -98.5 Thousand | -98.5 Thousand | 19.98 Million | 22.27 Million | 19.98 Million | -8.84 Million |
Investments in PPE | -1.39 Million | -1.39 Million | -2.61 Million | -13.19 Million | -2.61 Million | -3.98 Million |
Acquisitions | - | - | 870 Thousand | - | - | - |
Investment purchases | - | - | 1.01 Million | - | - | -2.62 Million |
Sales/Maturities of investments | 331 Thousand | - | - | -1.6 Million | - | - |
Other Investing Activities | 1.29 Million | 1.29 Million | 22.59 Million | 36.21 Million | 22.59 Million | -4.85 Million |
Financing Cash Flow | -22.11 Million | -22.11 Million | 969 Thousand | -27.77 Million | 969 Thousand | -14.85 Million |
Debt repayment | -50.29 Million | - | -30.85 Million | -47.55 Million | - | -26.56 Million |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | 30 Million | - | - |
Other Financing Activities | -22.11 Million | -22.11 Million | 969 Thousand | - | 969 Thousand | -14.85 Million |
Accounts receivables | -18.87 Million | -18.87 Million | 17.74 Million | - | 17.74 Million | 16.38 Million |
Accounts payables | 16.98 Million | - | -6.71 Million | - | - | -23.47 Million |
Inventory | -1.18 Million | -1.18 Million | 1.02 Million | 35.02 Million | 1.02 Million | 16.49 Million |
Other working capital | 6.81 Million | 6.81 Million | -9.13 Million | - | -9.13 Million | -6.45 Million |
Cash at beginning of period | 67.91 Million | - | 26.08 Million | 50.4 Million | 26.08 Million | 50.4 Million |
Cash at end of period | 20.2 Million | -23.85 Million | 67.91 Million | 67.91 Million | 46.99 Million | 26.08 Million |
Capital Expenditure | -1.39 Million | -1.39 Million | -2.61 Million | -13.19 Million | -2.61 Million | -3.98 Million |
Effect of forex changes on cash | -349.5 Thousand | -349.5 Thousand | 225 Thousand | -392 Thousand | 225 Thousand | -421 Thousand |
Net cash flow / Change in cash | -47.7 Million | -23.85 Million | 41.83 Million | 17.5 Million | 20.91 Million | -24.32 Million |
Free Cash Flow | -2.68 Million | -2.68 Million | -2.87 Million | 10.2 Million | -2.87 Million | 7.97 Million |
7717
SVNDY
ARIS
EIOF
COMSP
SURG